Pharmafile Logo
Pharmafocus logo
Advanced Search

Danger of Sanofi’s dengue vaccine confirmed in new study

June 14, 2018
Medical Communications, Research and Development Sanofi, biotech, dengue, dengvaxia, drugs, pharma, pharmaceutical

A study that thoroughly analyses the impact of Sanofi’s dengue vaccine has confirmed what was feared – children without prior …

News
mylan_building

FDA knocks back Mylan’s Advair generic for second time

June 14, 2018
Sales and Marketing Advair, FDA, GSK, Mylan, pharma

The FDA has rejected Mylan’s generic version of GlaxoSmithKline’s Advair for the second time following its knockback last year, citing …

News
nhs_parliament_2_4

UK immigration rules to be waived to bring in more doctors

June 14, 2018
Medical Communications NHS, biotech, drugs, pharma, pharmaceutical

The NHS’ recruitment crisis has been on-going for a number of years, with an ageing population and a higher workload …

News
line_of_people

Report highlights that half of women in science face harassment

June 14, 2018
Medical Communications biotech, drugs, pharma, pharmaceutical

Arriving at a particularly low point for the reputation of the biotech, after STAT revealed that a party at BIO …

News
apps_mobile

UK demand for mental health apps soars 566% since 2014

June 13, 2018
Medical Communications, Research and Development UK, apps, mental health, pharma

A new report from communications and research agencies GK Strategy and onefourzero has revealed the massive extent to which consumer …

News
vaccination-2722937_960_720

Vaccination rates in parts of US fall to dangerous levels

June 13, 2018
Research and Development anti-vax, biotech, drugs, pharma, pharmaceutical, vaccination

The anti-vaxxer movement is the scourge of meticulously researched science and yet, in certain states in the US, it seems …

News
celgene_1_02

Celgene showcases strong Otezla data in psoriatic arthritis

June 13, 2018
Research and Development Celgene, EULAR, otezla, pharma

Celgene has seized the opportunity at the Annual European Congress of Rheumatology in Amsterdam to reveal positive new data for …

News

J&J continues to shed assets, with $2.1bn diabetes unit sale

June 13, 2018
Research and Development, Sales and Marketing Johnson & Johnson, biotech, drugs, pharma, pharmaceutical

Just last week, Johnson & Johnson announced that it had received an offer from Fortive for its medical sterilisation unit, …

News
old_hands_stick

Investors stump up cash for anti-ageing start-up

June 12, 2018
Research and Development, Sales and Marketing Juvenescence, biotech, drugs, pharma, pharmaceutical

Defeating the ageing process is a pie-in-the-sky idea that has resulted, so far, in a rich vein of parody rather …

News
brexit

Brexit negotiations: Is the public’s health a priority?

June 12, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biotech, brexit, drugs, pharma, pharmaceutical

The Brexit decision has created a huge amount of question marks for many industries and each is vying with each …

Feature
dna-1903319_960_720

Research casts doubts over CRISPR safety

June 12, 2018
Manufacturing and Production, Research and Development biotech, crispr, drugs, pharma, pharmaceutical

Research emerging from two studies, published in same issue of Nature, has raised significant questions over just how safe CRISPR …

News
shutterstock_339308225

Vical terminates genital herpes vaccine after trial failure

June 12, 2018
Manufacturing and Production, Research and Development Vaccine, Vical, herpes, pharma

San Diego-based biopharma firm Vical has announced the disappointing, if unsurprising, news that it has taken the decision to terminate …

News
allergan

Allergan’s atogepant fulfils primary endpoint in episodic migraine

June 12, 2018
Manufacturing and Production, Research and Development Allergan, atogepant, migraine, pharma

Allergan has made ground in its quest to become “the headache company” with the release of new Phase 2b/3 data …

News
nerve-cell-2213009_960_720

Another failure in Alzheimer’s creates bleak outlook for treatment

June 12, 2018
Manufacturing and Production, Research and Development Alzheimer's, AstraZeneca, Eli Lilly, biotech, drugs, pharma, pharmaceutical

Finding a treatment for Alzheimer’s disease has been one of the aims of big pharma for last few decades, but …

News
handshake_2

Alexion goes back to roots with Complement deal

June 11, 2018
Manufacturing and Production, Sales and Marketing Alexion, biotech, drugs, pharma, pharmaceutical, soliris

Alexion has made a lot of money from investing in the science behind complement inhibitors – C5 inhibitor, Soliris, has …

News
thumbs_up

AbbVie/Roche gain FDA approval for blockbuster treatment

June 11, 2018
Sales and Marketing AbbVie, Roche, biotech, drugs, pharma, pharmaceutical

AbbVie and Roche have a chalked up a major success, after the FDA gave its approval for Venclexta, in combination …

News
canada_block_001_takeda

Takeda shareholders try to buck Shire deal

June 11, 2018
Sales and Marketing Shire, Takeda, biotech, drugs, pharma, pharmaceutical

A small group of Takeda shareholders have started making a lot of noise over its $62 billion deal for Shire, …

News
astrazeneca_logo_building

EU gives nod to expanded label for AZ’s Tagrisso

June 11, 2018
Sales and Marketing AstraZeneca, Tagrisso, biotech, drugs, pharma, pharmaceutical

AstraZeneca has scored another success with Tagrisso in Europe, by receiving an expanded marketing authorisation for Tagrisso in the first-line …

News
kendall_square_boston

Ipsen set to relocate North American HQ to Boston

June 11, 2018
Medical Communications, Sales and Marketing biotech, drugs, ipsen, pharma, pharmaceutical

Ipsen is set to join the ranks of a number of Boston-based biotechs, by setting up shop in Kendall Square. …

News
p_cagnoni_online

Rubius Therapeutics brings in new CEO

June 11, 2018
Medical Communications, Sales and Marketing Rubius Therapeutics, biotech, drugs, pharma, pharmaceutical

Rubius Therapeutics, a biotech that has ambitions to bring “super blood” to the market, has revealed that it has appointed …

News
The Gateway to Local Adoption Series

Latest content

Digital mental health technologies – a valuable tool in supporting people with depression and anxiety

January 29, 2026

Barts Health NHS Trust collaborates with H.I.G. Realty on healthcare innovation building

January 29, 2026

Rentschler Biopharma appoints Detra Glinatsis as Head of Business Development US

January 29, 2026

Five Facts about spinal muscular atrophy

January 28, 2026

Sobi’s Aspaveli receives European Commission approval for treatment of two rare kidney diseases

January 28, 2026